Xeldaxin

Medicinal product

(Invented) name

Xeldaxin

Active substance (s)

Deksketoprofenas

Strength

25 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis/Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M01AE17, Dexketoprofen

Marketing authorisation holder

Olpha AS, Latvija

Date of authorisation

2025-02-14

Date of renewal

Documents

5706_pakuotes lapelis_2025-02-14Nerp.docx

5706_pakuotes lapelis_2025-02-14Rp.docx

5706_Xeldaxin_Nerp.docx

5706_Xeldaxin_Rp.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

PT/H/2881/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Deksketoprofenas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116640	102739	1102739	lizdinė plokštelė	N10		Nereceptinis	LT/1/25/5706/001	Netiekiama	-	-	No	-	-
116641	102740	1102740	lizdinė plokštelė	N20		Receptinis	LT/1/25/5706/002	Netiekiama	-	-	No	-	-
116642	102741	1102741	lizdinė plokštelė	N30		Receptinis	LT/1/25/5706/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-02-14	Registruotas